A second health worker who cared for a person hospitalized in Missouri with H5N1 bird flu developed mild respiratory symptoms but was not tested for influenza, the Centers for Disease Control and Prevention reported on Friday. The CDC said Missouri health officials didn’t learn that the health worker had symptoms until after the individual had...

WASHINGTON — A federal appeals court ruled that three organizations, including the brand drug lobby PhRMA, can challenge Medicare’s drug price negotiation program in a lower court based in Texas.Continue to STAT+ to read the full story…

The Food and Drug Administration on Friday approved AstraZeneca’s bid to allow its nasal spray influenza vaccine, FluMist, to be sold for home administration.  Starting in fall 2025, people who want to order the vaccine to give it to themselves or their children at home will be able to do so. Read the rest…

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different...

Like all living things, cancer cells need to eat, and scientists have long tried to figure out how to starve tumors to death. A lot of that effort has focused on stifling the cells’ ability to digest glucose, a simple sugar thought to be the main food source for cancer. The glucose route has been ineffective, says William Lowry, a biologist at...

The Food and Drug Administration on Friday approved the first treatment for Niemann-Pick disease, type C, the culmination of years of advocacy and stutter-start drug development efforts in the rare neurological condition. The drug, known chemically as arimoclomol and now marketed as Miplyffa, was one of three that companies put in clinical trials...